npr glp 1 DR. BETSY DOVEC, #1 female weight loss surgeon and founder of @bodybybariatrics // interviewed with @npr for a radio interview and digital article on the topic of GLP-1s. Read the full interview Weight-loss drugs like Wegovy may
Description
By staying proactive and patient-centric, providers can help patients continue their weight-loss journey safely and effectively. Patients may feel frustrated, confused or anxious about losing access to medications that were working for them
However, the relevance of these findings to humans remains uncertain because human thyroid C-cells express GLP-1 receptors at much lower levels than rodent C-cells, suggesting potentially different susceptibility to GLP-1-mediated effects
The findings are not yet definitive, so they should not be used solely for cancer prevention
The first cohort comprised individuals who started and continued either a GLP-1 receptor agonist or DPP-4 inhibitor for the first time between January 1, 2007, and December 31, 2020
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
